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Abstract
Background General Pharmaceutical Council standards (UK) state ‘pharmacy professionals have 
the right to practise in line with their religion, personal values or beliefs as long as they …make 
sure that person-centred care is not compromised’, indicating a potential conflict for pharmacists 
who wish to exercise their right to conscientious objection (CO) to abortion while maintaining a 
duty of care to their patients.
Objective The objective of this study was to explore pharmacists’ views of conscientious objection 
to abortion and whether this included the supply of EC and the impact on practice.
Method Eighteen UK pharmacists were interviewed using semistructured interviews. Interviews 
were transcribed verbatim, imported into NVivo11 and analysed using thematic analysis.
Key findings Five themes were identified: beliefs as to what constitutes abortion, influences on be-
liefs, conflicts of conscience, accommodating conscience and professional obligations. Views were 
polarised in relation to the role of emergency contraception (EC) as an abortifacient. Religion was 
often viewed as the reason underpinning CO to abortion. Conflicts in relation to CO to abortion in-
cluded the role of referral and EC and employability for objectors. Some pharmacists viewed their 
role of providing patient choice as incompatible with the right of CO to abortion.
Conclusions This study shows the conflicts and challenges surrounding CO to abortion in profes-
sional pharmacy practice. While the majority of pharmacists believe CO to abortion should and 
could be accommodated, this can prove challenging in certain working environments, both in rela-
tion to ensuring a duty of care to patients is upheld and due to the ongoing debate concerning EC 
and whether it has a definitive role in abortion or not.
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Introduction
The ethical principle of conscientious objection (CO) to abortion is 
of interest to a wide spectrum of people such as ethicists, lawyers, 
politicians and health professionals. Section 4(1) of the 1967 Act 
provides that no one is under any duty to participate, contrary to 
his or her conscience, in any treatment authorised by the Act unless 
in a life threatening emergency.[1] When applying this in health care 
settings, it often becomes the centre of acrimonious debate.
The literature is divided as to the extent to which conscientious 
objection should be permitted, one author proposing that in some 
European countries laws need to be amended to ensure CO is not 
being utilised to undermine women’s access to abortion.[2] Wicclair 
debates the key issues of conscience and integrity in medicine, con-
cluding that “…there is a need for a more nuanced understanding 
and analysis of the relevant morals and values” (p.227).[3]
The major issue in relation to CO, in which community phar-
macists are involved is the supply of emergency contraception (EC), 
relevant legislation being introduced in 2001.[4] The primary contro-
versy with EC has been its possible abortifacient effect.[5] Debate has 
focused on the morality of its use and supply, and whether pharma-
cists may refuse to supply it on moral or religious grounds.[6, 7] An 
understanding of the mechanism of action of EC is thus essential to 
discussing ethical issues of these products, although a detailed review 
of their pharmacology is beyond the scope of the current paper. The 
outcome of administration of any drug used in this context is likely 
to depend upon the dose and timing of administration in relation to 
the menstrual cycle.[8]
The most common EC regimen is effective if taken within 72 h 
of unprotected intercourse although it is sometimes used with 
diminishing effectiveness between 72 and 96 h.[9] A recent Cochrane 
review investigating the comparative effectiveness and safety ra-
ther than the mechanism, of interventions for EC, concluded that 
levonorgesterol cannot prevent implantation of a fertilised egg.[10] 
This review supports another judgement seemingly held, although 
less confidently asserted, by the authors of a systematic review more 
directly concerned with mechanistic actions.[8] However, many of the 
studies upon which this judgment seems to rest have limitations in 
respect of external validity because they were conducted in cell cul-
ture models,[11, 12] included small numbers of participants[13] or meas-
ured surrogate endometrial markers.[14] Therefore, such judgements 
seem to be based upon an ‘absence of evidence’ rather than ‘evidence 
of absence’.
An alternative drug, ulipristal acetate, administered as a single 
30 mg dose, is thought to be effective if taken up to 120 h after unpro-
tected intercourse.[9] A systematic review points to pre-fertilisation 
mechanisms being responsible for the effects of ulipristal, but 
calls for more research.[15] Such research should not exclude post-
ovulatory mechanisms, and another recent review of the evidence 
concludes that, dependent upon timing, post-ovulatory mechanisms 
might contribute to the clinical effectiveness of ulipristal.[16] An al-
ternative progesterone receptor modulator, mifepristone, has been 
shown both to inhibit implantation and induce abortion, although 
at higher doses typically used in EC.[17] Such research has influenced 
the General Pharmaceutical Council’s standards. In essence the lack 
of consensus as to whether EC can in some cases be considered abor-
tion, mirrors the dilemmas concerning the medical profession and, 
those of nursing and midwifery.[18, 19]
There are very few published UK-based studies utilising empirical 
research on matters of conscience in pharmacy. Cooper et al.’s quali-
tative study of community pharmacists’ views of ethical and religious 
beliefs influencing their thoughts on EC reported mixed views, re-
flecting those of other professions[20] and concluded that their sample 
viewed ethical issues in a legalistic, self-interested way thus finding it 
difficult to discuss ethical issues and reflect upon patients’ and phar-
macists’ values in a broader context. A more recent systematic re-
view of pharmacy users’ and staff experiences and attitudes towards 
the delivery of a large range of pharmacy-based sexual health serv-
ices included three studies from England and one from Scotland spe-
cifically concerned with conscience and EC.[21] Another study of 126 
pharmacists in Poland concluded that 15% of participants would 
exercise the right to conscientious objection if the European Council 
Resolution on Conscientious Objection[22] were legally sanctioned in 
Poland, although this is actually the case.[23, 24] A study omitted from 
the review,[21] reports from a survey of 1975 pharmacists in Nevada 
concluded that religion significantly predicted pharmacists’ willing-
ness to dispense EC. The authors’ analyses showed that “Catholics 
and evangelical Protestants were significantly more likely to refuse 
to dispense at least one medication in comparison to non-religious 
pharmacists” [p.161].[25]
There is clearly a paucity of empirical literature and this study 
aims to address some of the gaps. Thus the aim of this study is to 
explore pharmacists’ views of conscientious objection to abortion 
and whether they believed this also included the supply of EC and 
the impact on practice in two UK locations.
Method
Ethical approval was granted by Liverpool John Moores University 
(UREC 18/NAH032) and was ratified by the Health Research 
Authority (246528).
A qualitative study, using semi-structured face-to-face inter-
views was undertaken to capture rich, in-depth data on a subject 
that was potentially emotive.[26] Key interview questions were devel-
oped from an extensive literature review aligned to the study aim. 
Open-ended questions and prompts were included in order to fa-
cilitate exploration of the participants’ views and experiences while 
maintaining a focus on the subject matter per se (see Table 1 for 
interview schedule).
Table 1 Interview schedule
Can you tell me about your role in advising women who are seeking 
advice relating to pregnancy termination? How do you feel about 
that? Is this something you come across often in the work you carry 
out?
Tell me, is prescribing or dispensing the morning after pill something 
you come across often? How do you feel about this personally?
What, in your opinion, constitutes ‘participation’ in the procedure of 
termination?
What does ‘conscientious objection’ mean to you?
What do you identify as the limitations to CO as a pharmacist? What 
are you own limits?
What has helped to form your views?
Did you have any particular views on this prior to commencing work in 
the profession?
Have your views changed over the time you have worked in the 
profession?
Have you ever refused or considered refusing to give EC? What were 
the circumstances? What happened? How did it make you feel?
Do you know anyone who has refused/objected to give EC? What were 
the circumstances? What happened? How do you feel about this?
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Figure 1 Themes from interview data.
Inclusion criteria required the pharmacists to be UK registered 
and currently practising in hospital or community pharmacy settings 
in either the Liverpool or Glasgow areas, chosen because they pro-
vide the full range of abortion services available overall in the UK. 
Working as a locum did not preclude pharmacists from the study 
and they could have any number of years’ experience, including 
being newly qualified. The broad nature of the inclusion criteria was 
a deliberate attempt to capture data which represented a diversity of 
views, experiences and perspectives held by the participants.
A multi-method approach to recruitment was adopted. Hospital-
based pharmacists were recruited via research department coord-
inators who emailed the study information and research team’s 
contact details to them. In addition, a research poster was displayed 
in hospitals with the research team’s contact details. Participants 
were also recruited through ‘snowballing’, a sampling technique 
whereby ‘insiders’ locate further respondents to participate.[26, 27] 
Participants, who had been interviewed disseminated the study in-
formation to other colleagues via email and/or text. The study in-
formation was posted on a local health professional Facebook 
page serving Liverpool; however, no participants responded to this. 
Recruitment was undertaken over 1 year. All interviews took place 
at a time and setting convenient to the participant such as their place 
of work, their own home or a neutral setting, lasted 28–74 min and 
were audio digitally recorded. Three team members (C.M., C.H. and 
J.M.) undertook the interviews between April 2019 and March 
2020. Consistency between the interviewers was attained by use of 
the interview schedule and by regular meetings to reflect upon and 
discuss the interviews. The interviews were transcribed verbatim, 
with all identifiers removed to ensure anonymity. Participants were 
allocated randomly selected pseudonyms during coding to maintain 
confidentiality.
Data analysis was undertaken manually by two authors 
(C.H. and J.M.) using Braun and Clarke’s six stage thematic analysis 
to ensure that a systematic yet flexible inductive, data-driven ap-
proach was employed.[28, 29] In order to ensure a rigorous and trans-
parent process of analysis, initial codes and themes were developed 
by the person who had carried out the interview. Transcripts were 
then swapped between authors and the same process applied, en-
suring each interview was independently coded and themed twice. 
The emergent codes and themes from all of the interviews were then 
reviewed by two authors (C.H. and C.M.). A high similarity index 
between the two sets of codes and themes was noted and minor 
changes were made to the theme names. A final step to further ana-
lytical rigour was undertaken by a third author not involved in the 
interviews (V.F.). Using a ‘fresh eyes’ approach the author reviewed 
the codes, themes and verbatim comments for constructive align-
ment and again only minor changes were made. Five themes emerged 
from the data (Figure 1).
Results
Twenty participants were recruited, however due to two ‘no shows’ 
18 were ultimately interviewed. It was agreed among the team that 
data saturation had been reached after the 18 interviews due to no 
new codes and themes emerging. (see Table 2 for participant demo-
graphics using pseudonyms).
Beliefs as to what constitutes abortion
This theme focuses on the role of EC as a potential abortifacient 
which was closely linked to individual interpretations of foetal via-
bility. These interpretations were polarised at times,
…we are not letting a baby grow…you are kind of killing the 
baby, indirectly.” Philip Some people say right, anything that 
happens to that fertilised egg after that would be classed as an 
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Table 2 Participant demographics
Pharmacist pseudonym Years of experience Place of work Objector?
Pamela 15 Community based No
Pascal 20 Community based No
Patricia 7 Community based No
Patrick 7 Community based No
Paul 20+ Hospital based Yes
Paula 14 Hospital based Yes
Pauline 30+ Community based No
Pedro 12 Community based No
Penny 10 Community based No
Percy 18 Hospital based Yes
Peter 2 Hospital based No
Petra 25+ Hospital based No
Petronella 1 Hospital based No
Phillip 3 Hospital based Yes
Phillipa 7 Hospital based Yes
Phoebe 30 Hospital based No
Pearce 12 Hospital based No
Poppy 10+ Community based Yes
Many participants perceived their role as being ‘removed’ from 
participating in abortion particularly in relation to the supply of EC 
or abortifacients. This was often framed in practical terms,
It’s a business transaction” Paula
Influences on beliefs
This theme illustrates the key drivers underpinning abortion beliefs. 
Although some participants described this in terms of past personal 
experiences, the majority cited religion as the main influence,
Fundamentally, I’d say I am an objector. Part of that is reli-
gion, upbringing.” Philippa
Interestingly one pharmacist described how CO being based on 
religion was problematic due to it potentially ‘opening up’ the right 
to CO,
 “It’s important that the debate isn’t about religion …you can 
end up with a really kind of relativist situation there where 
people kind of claim all kinds of exemptions from all kinds 
of things. And then you know religion ends up trumping all 
sorts of other considerations and I don’t think that’s neces-
sarily helpful.” Paul
Conflicts of conscience
The theme exhibits the complexities associated with a pharmacist’s 
right to exercise CO. This could be impacted by work environment,
Whenever you’re locuming, you can’t really enforce your 
own opinions or beliefs. If the pharmacist offers that as a 
service… you can’t really, as the locum, turn that customer 
away” Philippa
In addition, a number of participants highlighted the contradic-
tions and complexities in relation to referral and participation in 
abortion,
..I think a kind of direct referral to someone else would kind 
of feel like some direct or I guess indirect participation …I 
can’t say I’d feel entirely comfortable about it…” Paul
 “…you can signpost to somewhere where they can get it, 
which sort of undermines the objection in the first place.” 
Patricia
Participants also discussed the possible conflicts emerging within 
their changing role, particularly in relation to the provision of EC,
I guess in a situation where you don’t come into any con-
tact with abortion in your work place you don’t necessarily 
feel the need to advertise your objection to that. But when 
something changes then that becomes a problem doesn’t it?” 
Poppy
A number of participants discussed the conflict between ‘employ-
ability’ and the right to exercise CO, describing how in certain envir-
onments this would be problematic,
I’d be cautious of perhaps working in an environment where 
… you don’t get another pharmacy for miles around so then 
that might become an issue for you.” Paul
Accommodating conscience
The theme ‘focuses on facilitating CO in practice. All of the partici-
pants knew that CO was a pharmacist’s right and most discussed the 
need to refer if CO was exercised. Many felt strongly that it was im-
portant to ‘refer on’ in order to protect the patient, with some viewing 
this as a ‘dereliction of care’ if it was not undertaken. However, par-
ticipants were not always clear on referral requirements,
I don’t know if it’s unethical not to signpost them…” 
Petronella
In line with this, almost all of the participants described their 
pharmacy education/training as having very little or no discussion 
surrounding CO.
Most participants believed CO could be accommodated within 
pharmacy practice. However, some highlighted that accommodation 
was more challenging in community and that referral was essential 
in this case
Many of the participants highlighted the lack of clear guidance 
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the development of such guidelines was equally problematic due to 
‘grey areas’ and individual circumstances,
 “…it’s difficult to have a clear guideline… because there is 
not a scenario that would be the same..” Percy
It was evident that for a minority of participants a guideline was 
not required due to them believing that the conscience clause should 
not be available,
… I believe quite strongly that pharmacists, doctors, what-
ever shouldn’t have a right to say no to these people. ….per-
sonally I don’t think that clause should be there…” Pedro
Professional obligations
The theme encompasses the participants’ views on their role in re-
lation to providing information on EC. This was often described 
in terms of providing ‘choice’ to patients. Many of the participants 
described how patient choice should be the priority, although they 
noted that this was not always straightforward to facilitate when 
a colleague objected, this was depicted as a ‘delicate balance’ 
(Philippa). Some participants did not believe colleagues should have 
the right to refuse EC, with the right to CO being viewed as ‘incom-
patible’ with their profession,
But you come in to this job knowing that services like this 
are in place….so I mean if you are that strongly viewed then 
maybe this career is not for you.” Pearce
Discussion
The five themes that emerged from the data partially support in the 
findings from previous studies but also shed new light on the topic. 
While we were seeking information about participants’ views on CO 
rather than their own beliefs on abortion, the latter were offered by 
most participants who determined it as being in relation to when a 
foetus is deemed viable. This complex and at times subjective issue, 
was highlighted earlier in this paper, with the participants’ some-
times polarised views as to whether EC could induce abortion being 
illustrative of the ongoing debate surrounding this. However, most 
spoke only hypothetically about their own involvement in abortion 
via the dispensing of EC or abortifacients, even though they were 
asked directly at interview about their experiences in relation to this. 
This then led to their thoughts as to whether CO was of any rele-
vance to their practice, revealing a level of ‘detachment’ adopted be-
tween them and any potential contribution to participating in the 
abortion procedure. This detachment of the participants from the 
topic takes a different view from the findings of Cooper et  al.[20] 
who noted that the 23 pharmacists in their qualitative study spoke 
in a self-interested way. In considering that findings of that study 
their three categories were determined from the top down reflecting 
whether or not their sample was prepared to dispense emergency 
contraception giving consideration to ethical, religious and practical, 
concerns, whereas our themes were data driven.
Participants in this study also offered their views as to what in-
fluenced their own or others’ beliefs. Overwhelmingly, they put this 
down to religion with Catholics and Muslims being mentioned by a 
number of participants as being the colleagues who were most likely 
to object to providing EC. This counters the findings of Fleming 
et al.’s systematic review of reasons for conscientious objection,[19] 
which examined 10 articles from an initial field of 1085. In the 10 
articles, 81 reasons argued in favour of and 35 against conscientious 
objection. Using predetermined categories of moral, practical, reli-
gious or legal reasons, ‘moral reasons’ contained the largest number 
of reasons. The reasons and their associated mentions in this category 
exceeded those in the sum of the other three categories, with prac-
tical reasons (n = 30) also outnumbering religious reasons (n = 15). 
However, there are many papers which have drawn upon religion as 
the main influence on CO and its influence cannot be disputed.[18, 30]
Participants also highlighted some of the conflicts of conscience 
they experienced in their practice and how these could potentially 
be accommodated. Two acknowledged the enigma of referral by ob-
jectors to other pharmacists, which is a requirement of the current 
standards of the General Pharmaceutical Council.[31] As with other 
studies, this is a controversial topic as some authors feel that by re-
ferring, one becomes complicit in the abortion.[5]
Other dilemmas included changes within the participants’ role, 
particularly pertinent for those who have experienced the move to 
‘over the counter’ supply of EC. This mirrors the situation in two 
recent cases of conscientious objection by midwives each of which 
reached the highest courts in their countries. One of them concerned 
two midwives who had been in their existing jobs for many years 
and the other a newly qualified midwife who was unable to secure 
employment in their home country after the midwife’s status as an 
objector was made known.[32] While the grounds for these midwives’ 
objections were the same, considering them from an employment 
perspective, the scenarios required different approaches to accom-
modating or rejecting their requests. The dilemma of the evolving 
role of pharmacists however, was not shared by all of the participants 
in the present study, and as with the theme concerning their beliefs 
about abortion, there was an overall sense of ‘removal’ with parti-
cipants expressing that they were several steps away from abortion.
Although it is evident from this study that accommodation of 
CO in pharmacy practice is riddled with complexities, the majority 
of the participants recognise it should be a person’s right to exercise 
it. This is in contrast to Fiala and Arthur who did not acknowledge 
the term but rename it ‘dishonourable disobedience’.[33] However, 
this study brings to the fore a number of shortcomings concerning 
accommodating CO in pharmacy practice, which include lack of 
training around the subject, unclear guidance to work with and lack 
of knowledge in relating to referral and signposting.
The final theme of professional obligations is where the parti-
cipants showed a considerable degree of insight, expressing that it 
was sometimes a difficult issue. However, whatever their own per-
sonal views, the majority felt that the client should come first. This 
supports the findings of Brock[34] who noted that “each profession 
has a responsibility to provide to the public a competent level of 
services—medical or pharmaceutical—and to monitor its individual 
members to assure that they do so” (p.192). When providing emer-
gency contraception, it is the pharmacists themselves, rather than 
their assistants, who are required to serve the woman or the person 
she has designated on her behalf. As part of that service they collect 
certain demographic and health related data to assist them in deter-
mining whether or not to dispense the drug and offer advice about 
such things as longer term contraception. Thus, as Pellegrino[18] has 
pointed out an objector who is forced into providing the service may 
not be in the best position to advise the patient or their agent ap-
propriately if they lack the necessary frame of mind to provide an 
empathetic service.
This study is the first of its kind to explore UK pharmacists’ 
views on CO to abortion and provides a unique insight into how 
this can impact upon their practice. While we aimed to recruit as di-
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in remote areas where other challenges may be expected. We recom-
mend that future research focuses on this particular group to explore 
the challenges they may encounter. Being a qualitative study it is not 
intended to be generalisable, but findings may be transferrable to 
pharmacists in other areas of the UK and internationally who read 
this article. The findings are particularly useful in highlighting the 
potential complexities of CO to abortion which can be used to open 
up dialogue and debate within day to day pharmacy practice and 
also further afield, concerning areas such as education and guide-
lines. Further research is needed to capture a wider range of phar-
macists’ views on CO to abortion. The authors of this paper are 
currently developing a national survey informed by this study’s find-
ings to investigate this.
Conclusion
While the majority of participants in this study believe CO to 
abortion should and could be accommodated, they also have a 
strong professional obligation to their patients, which can prove 
challenging for those who object. This appears to be exacerbated 
by certain working environments and also where there may be a 
deficit in training surrounding the subject of CO and a lack of 
clear guidelines. Furthermore, the issue of referral and whether 
it has an active role in participation in abortion is equally prob-
lematic and very much open to interpretation. Finally, the issue of 
the exact mechanism of action of EC and how this interacts with 
fertilisation remains open to debate and until the pharmaceutical 
evidence is conclusive this will continue to remain so. Leung et al. 
(2010) concluded that “For those who object to the use of emer-
gency contraceptives because there is insufficient evidence to com-
pletely exclude the possibility of interference with implantation, 
emergency contraceptives are not acceptable contraceptives.”[8] 
This would still seem to be an accurate reflection of the situation 
10 years later.
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